Structural Characterisation of Aggrecan in Cartilaginous Tissues and Tissue Engineered Constructs a Thesis Submitted to the Univ

Structural Characterisation of Aggrecan in Cartilaginous Tissues and Tissue Engineered Constructs a Thesis Submitted to the Univ

Structural Characterisation of Aggrecan in Cartilaginous Tissues and Tissue Engineered Constructs A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Biology, Medicine and Health 2017 Russell J Craddock The School of Biological Sciences Division of Cell Matrix Biology and Regenerative Medicine List of Contents List of Contents ................................................................................................................. 2 List of Figures ................................................................................................................... 6 List of Tables ..................................................................................................................... 8 List of Equations ............................................................................................................... 8 List of Conference Presentations and Publications ....................................................... 8 List of Abbreviations ........................................................................................................ 9 Abstract ........................................................................................................................... 10 Declaration ...................................................................................................................... 11 Copyright Statement ...................................................................................................... 11 Acknowledgements ......................................................................................................... 12 1 Chapter 1: General Introduction ............................................................................... 13 1.1 Overview .................................................................................................................... 14 1.1.2 Intervertebral Disc Biology ..................................................................................... 15 1.1.3 Intervertebral Disc Macrostructure.......................................................................... 16 1.1.3.1 Nucleus Pulposus ................................................................................................. 16 1.1.3.2 Annulus Fibrosus .................................................................................................. 16 1.1.3.3 Cartilage End-plates ............................................................................................. 17 1.1.4 Articular Cartilage ................................................................................................... 17 1.1.5 Structural differences between nucleus pulposus and articular cartliage ................ 18 1.1.6 Extracellular Matrix Molecules and Assemblies in Intervertebral Discs ................ 19 1.1.6.1 Collagen ................................................................................................................ 19 1.1.6.2 Proteogylcans ....................................................................................................... 20 1.1.6.3 Aggrecan .............................................................................................................. 21 1.1.6.3.1 Transcription of Aggrecan ................................................................................. 21 1.1.6.3.2 Aggrecan Core Protein Structure....................................................................... 22 1.1.6.3.3 Biosynthesis of Aggrecan .................................................................................. 24 1.1.6.3.4 Aggrecan Functionality and Protein Interactions .............................................. 27 1.1.6.3.5 Tissue-specific Variability in Aggrecan Structure ............................................ 27 1.1.6.3.6 Fragmentation/degradation of aggrecan ............................................................ 29 1.2 Hypothesis and aims of the project ............................................................................ 33 2 Chapter 2: General Methods ...................................................................................... 34 2.1 Cartilaginous tissue collection .................................................................................... 35 2.1.1 Native tissue sample collection ............................................................................... 35 2.1.2 Isolation and culture of nucleus pulposus cells ....................................................... 35 2.1.3 Encapsulation of nucleus pulposus cells in a type I collagen hydrogel .................. 36 2.1.4 Chondrogenic stimulation of encapsulated nucleus pulposus cells with GDF6/TGFβ3 ................................................................................................................... 36 2.2 Isolation and characterisation of aggrecan ................................................................. 36 2.2.1 Aggrecan isolation by dissociative caesium chloride centrifugation ...................... 36 2.2.2 Preparation of aggrecan for structural characterisation ........................................... 38 2.2.3 Structural Characterisation of aggrecan by atomic force microscopy and multi- angle light scattering ........................................................................................................ 41 2.3 Histological assessment of tissue composition and collagen fibril alignment ........... 45 2.3.1 Histological staining ................................................................................................ 45 2.3.2 Characterisation of collagen fibril ultrastructure by atomic force microscopy ....... 46 2.4 Measurement of micro-mechanical compressive stiffness by atomic force microscopy indentation .................................................................................................... 48 2.5 Relative gelatinase activity determined by in situ gelatinase zymography ................ 50 2.6 Computational modelling of aggrecan packing .......................................................... 51 2 2.7 Gene expression analysis using real-time quantitative-PCR ...................................... 52 2.7.1 Isolation of RNA from NP cell constructs .............................................................. 52 2.7.2 Reverse transcription of RNA ................................................................................. 53 2.7.3 Assessment of NP marker gene expression with real-time quantitative-PCR ........ 53 2.8 Statistical Analysis ..................................................................................................... 54 3 Chapter 3: Characterisation of aggrecan and collagen structure in young, healthy cartilaginous tissues ........................................................................................................ 55 3.1 Introduction .............................................................................................................. 56 3.1.2 Hypothesis and aims ................................................................................................ 57 3.2 Materials and methods ............................................................................................. 58 3.2.1 Experimental design ................................................................................................ 58 3.3 Results ........................................................................................................................ 59 3.3.1 The ultrastructure of intact aggrecan monomers was tissue-specific ...................... 59 3.3.2 Most isolated aggrecan molecules were fragmented and structurally heterogeneous ................................................................................................................... 59 3.3.3 Aggrecan fragmentation was not associated with aberrant structural or mechanical tissue remodelling or excessive protease activity ............................................................. 62 3.3.4 Aggrecan fragmentation was predicted to modulate molecular packing density .... 68 3.4 Discussion .................................................................................................................. 70 3.5 Conclusions ............................................................................................................... 75 4 Chapter 4: The effect of culture conditions on the nanostructure of aggrecan and mechanical properties in intervertebral disc tissue engineered constructs .............. 76 4.1 Introduction .............................................................................................................. 77 4.1.2 Hypothesis and aims ................................................................................................ 79 4.2 Materials and methods ............................................................................................. 80 4.2.2 Experimental design ................................................................................................ 80 4.3 Results ........................................................................................................................ 82 4.3.1 The effect of oxygen on aggrecan synthesis and structure ...................................... 82 4.3.1.1 Oxygen tension did not affect the proportion of intact aggrecan, but did affect molecular size ................................................................................................................... 82 4.3.1.2 Gene expression aggrecan was reduced in hypoxic conditions compared to normoxia

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    156 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us